Filing Details
- Accession Number:
- 0000950170-23-042406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-14 16:09:28
- Reporting Period:
- 2023-08-11
- Accepted Time:
- 2023-08-14 16:09:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1796129 | Vincerx Pharma Inc. | VINC | Pharmaceutical Preparations (2834) | 833197402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1832562 | A. Alexander Seelenberger | 260 Sheridan Avenue, Suite 400 Palo Alto CA 94306 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-11 | 10,500 | $0.95 | 30,280 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents a weighted average purchase price. Actual purchase prices ranged from $0.9374 to $0.9499 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
- Includes 2,287 shares and 5,000 shares of common stock acquired on May 13, 2022 and May 12, 2023, respectively, under the Vincerx Pharma, Inc. 2021 Employee Stock Purchase Plan.
Billionaire Hedge Funds
